Therapie der Multiplen Sklerose mit Fingolimod-Reference-Cited by-同舟云学术

Therapie der Multiplen Sklerose mit Fingolimod

Published:2011-08-17 Issue:2 Volume:83 Page:236-242
ISSN:0028-2804
Container-title:Der Nervenarzt
language:de
Short-container-title:Nervenarzt

Author:

Winkelmann A.,Löbermann M.,Reisinger E.C.,Zettl U.K.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Neurology,Neurology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00115-011-3360-1.pdf

Reference20 articles.

1. Aktas O, Ingwersen J, Kieseier B et al (2011) Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system. Nervenarzt 82:215–225

2. Cohen JA, Barkhof F, Comi G et al (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362:402–415

3. Cohen JA, Chun J (2011) Mechanisms of fingolimod’s efficacy and adverse effects in multiple sclerosis. Ann Neurol 69:759–777

4. EMA (2011) Gilenya: EPAR – Product Information. 30/03/2011. Online: www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002202/WC500104528.pdf

5. FDA (2010) Gilenya-Approved Labeling Text. 21 September 2010. Online: www.accessdata.fda.gov/drugsatfda_docs/label/2010/022527s000lbl.pdf

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Literatur;Multiple Sklerose;2022

2. Varicella-zoster- und Herpes-zoster-Impfindikation bei Multipler Sklerose: aktuelle Situation;Der Nervenarzt;2019-09-17

3. FTY-720 induces apoptosis in neuroblastoma via multiple signaling pathways;Oncotarget;2017-11-06

4. Biologika und Infektionen;rheuma plus;2016-05-24

5. Herpes zoster: a potential risk associated with fingolimod treatment;International Journal of Dermatology;2015-07-14